The Allstate is trading at $249.26, down 4.08% versus the October 30 close; no verified company-specific catalyst explains the decline.
- Available coverage conflicts with the supplied price context. The latest company-specific coverage concerns previously reported catastrophe losses, not a new announcement.
- Third-quarter results are scheduled for November 4 after 4:15 p.m. ET; no evidence links the report to the move.
- Major indices are positive in the provided market context, so broad-market strength does not explain the decline.